Tag Archives: AstraZeneca

Prime Minister Narendra Modi will fly to Hyderabad, Ahmedabad and Pune on Saturday to take stock of the development of the COVID-19 vaccine on the premises there. Modi will visit the plant of the main pharmaceutical Zydus Cadila in Ahmedabad to obtain information on the development of its vaccine, said …

BEIJING: Before a planned trip to the US, Cheng wanted to get vaccinated against Covid-19. To do so, he asked a friend who worked at a cold chain logistics company in southeastern China to pretend he was an employee of the company, allowing Cheng to access one of the country’s …

NEW DELHI: India will consider clinical trial data for the two full-dose Oxford-AstraZeneca Covid-19 vaccine candidates, which the firm says is 62% effective and not the “more complete half” dose regimen, which is claimed to be up to 90% effective, but has drawn criticism for dosing errors. the Indian governmentThe …

AstraZeneca is likely to conduct a further global trial to assess the efficacy of its COVID-19 vaccine, its chief executive, Pascal Soriot, said Thursday after questions about the results of its late-stage study. Rather than adding the trial arm to an ongoing process in the US, a new study would …

Earlier this week, AstraZeneca PLC and the University of Oxford said their vaccine candidate was 62% to 90% effective, joining two other Western vaccine rivals in providing data. The results could allow the US and other countries to grant regulatory clearance and prepare distribution plans for widespread vaccination. Chinese vaccine …

AstraZeneca Plc and the University of Oxford, among the pioneers in the quest to deliver a Covid-19 vaccine, face growing questions about their trial results after acknowledging a manufacturing error. While an announcement Monday from Astra and Oxford showed their shot was 70% effective on average in a late-stage study, …

AstraZeneca Plc is likely to conduct an additional global trial to assess the efficacy of its Covid-19 vaccine, according to the company’s chief executive, after current studies raised questions about its level of protection. The new trial would be conducted rather than adding an arm to an ongoing trial in …

Less than a year after an unknown coronavirus that has claimed 1.4 million lives began to spread around the world, several very promising Covid-19 vaccines are about to be released. Health authorities could give the green light for emergency use in a few weeks, marking the fastest vaccine development for …

AstraZeneca Plc is likely to conduct an additional global trial to assess the efficacy of its Covid-19 vaccine, according to the company’s chief executive, after current studies raised questions about its level of protection. The new trial would be conducted rather than adding an arm to an ongoing trial in …

Astra faces scrutiny as she responds to growing confusion about the vaccine. (Figurative) AstraZeneca Plc is likely to conduct an additional global trial to assess the efficacy of its Covid-19 vaccine, according to the company’s chief executive, after current studies raised questions about its level of protection. The new trial …